We are looking to form strategic partnerships for cell engineering workflows and cell line development alongside rapid manufacturing of biologics, including CAR-T cells and hematopoietic stem cells. Feel free to explore our current pipelines in development or reach out to talk with us about a new possibility. We can also license our technology to support your workflows.